Abstract: The present invention relates to a synapse formation promoter and a brain plasticity promoter comprising CD24-negative mesenchymal stem cells prepared from a patient's own bone marrow aspirate and treatment of dementia, chronic-phase cerebral infarction, chronic-phase spinal cord injury, mental diseases, and the like using the synapse formation promoter and brain plasticity promoter.

Abstract: The present invention relates to a synapse formation promoter and a brain plasticity promoter comprising CD24-negative mesenchymal stem cells prepared from a patient's own bone marrow aspirate and treatment of dementia, chronic-phase cerebral infarction, chronic-phase spinal cord injury, mental diseases, and the like using the synapse formation promoter and brain plasticity promoter.

Abstract: There is provided an imaging apparatus, an imaging method, and a program, capable of easily obtaining an image captured from a desired position. By using distance information from an imaging position to a subject and model information, a virtual image obtained by imaging the subject from a virtual imaging position different from the imaging position is generated from a captured image obtained by imaging the subject from the imaging position. The present technology can be applied to, for example, an imaging apparatus that images a subject.

Abstract: The present invention relates to a pharmaceutical composition for treating amyotrophic lateral sclerosis. More specifically, the present invention relates to a pharmaceutical composition for treating amyotrophic lateral sclerosis, wherein the pharmaceutical composition comprises mesenchymal stem cells and is intravenously administered.

Abstract: The present invention relates to a pharmaceutical composition containing mesenchymal stem cells administered to a patient subjected to stenting. The present invention relates specifically to: a pharmaceutical composition for repairing and regenerating tissue, comprising mesenchymal stem cells, wherein the pharmaceutical composition is administered to a patient subjected to stenting; and the prevention of in-stent neointimal hyperplasia or in-stent restenosis with the pharmaceutical composition.

Abstract: The present invention relates to a life extension agent containing CD24-negative mesenchymal stem cells and the treatment of dementia, cerebral infarction, spinal cord injury and the like using the life extension agent.

Abstract: The present invention relates to a synapse formation promoter and a brain plasticity promoter comprising CD24-negative mesenchymal stem cells prepared from a patient's own bone marrow aspirate and treatment of dementia, chronic-phase cerebral infarction, chronic-phase spinal cord injury, mental diseases, and the like using the synapse formation promoter and brain plasticity promoter.

Abstract: Provided is new means for reducing risk of cerebral hemorrhage associated with a reperfusion therapy for vessel occlusion (for example, administration of a medicament including a thrombolytic agent, a platelet aggregation inhibitor, and an anticoagulant agent, or physical removal of a blood clot) and treating an ischemic vascular disorder more effectively. The present invention relates to a medicament for treating an ischemic vascular disorder, comprising mesenchymal stem cells, wherein the medicament is used in combination with a reperfusion therapy for vessel occlusion and more specifically, to a medicament for treating an ischemic vascular disorder, wherein the medicament reduces risk of cerebral hemorrhage associated with the reperfusion therapy for vessel occlusion and extends a time window in which the therapy is applicable.

Abstract: The object of the invention is to provide animal model of disorder and method of screening an agent for preventing or treating Metabolic Syndrome by using the animal model, wherein said animal model is used as experimental material which is essential to detailed analysis of component and pathologic condition of Metabolic Syndrome and to development of the method for treating and the agent for preventing and treating the Metabolic Syndrome. The above object is achieved by the non-human mammal model of disorders, whose TBP-2 gene is functionally deficient on chromosome, wherein the disorders are caused by impaired fatty acid utilization, and a method of screening an agent for preventing or treating Metabolic syndrome comprising; administering a test article to the non-human mammal whose TBP-2 gene is functionally deficient on chromosome.

Abstract: The object of the invention is to provide animal model of disorder and method of screening an agent for preventing or treating Metabolic Syndrome by using the animal model, wherein said animal model is used as experimental material which is essential to detailed analysis of component and pathologic condition of Metabolic Syndrome and to development of the method for treating and the agent for preventing and treating the Metabolic Syndrome. The above object is achieved by the non-human mammal model of disorders, whose TBP-2 gene is functionally deficient on chromosome, wherein the disorders are caused by impaired fatty acid utilization, and a method of screening an agent for preventing or treating Metabolic syndrome comprising; administering a test article to the non-human mammal whose TBP-2 gene is functionally deficient on chromosome.

Abstract: A print-order receiving apparatus is capable of receiving a customer's order for photographic prints through a recording medium electronically recording image data therein. The apparatus includes a box-like apparatus body, a slot formed in the apparatus body for attaching the recording medium and a reading driver unit for reading the image date from the recording medium as attached in the slot. The slot defines an aperture plane with its peripheral edges, the aperture plane being upwardly inclined.

Abstract: A print-order receiving apparatus is capable of receiving a customer's order for photographic prints through a recording medium electronically recording image data therein. The apparatus includes a box-like apparatus body, a slot formed in the apparatus body for attaching the recording medium and a reading driver unit for reading the image date from the recording medium as attached in the slot. The slot defines an aperture plane with its peripheral edges, the aperture plane being upwardly inclined.

Abstract: A reversibly operatable refrigerant circulating circuit (1) is formed in such a manner that a compressor (21), an outdoor heat exchanger (23), a motor-operated expansion valve (25) through which refrigerant flows in both directions and an indoor heat exchanger (31) are connected in this order. Between the motor-operated expansion valve (25) and the indoor heat exchanger (31), there is provided a refrigerant regulator (4) for regulating a circulation amount of refrigerant in a cooling operation cycle and storing liquefied refrigerant in a heating operation cycle. The refrigerant regulator (4) has a first flow pipe (42) to which the outdoor heat exchanger (23) is connected and a second flow pipe (43) which has plural refrigerant holes (45, 45 . . . ) and to which the indoor heat exchanger (31) is connected.